|  | |
| Names | |
|---|---|
| IUPAC name N′,3-Dihydroxy-4-naphthalen-1-yloxybutanimidamide | |
| Identifiers | |
| 
 | |
| 3D model (JSmol) | |
| ChemSpider | |
| EC Number | 
 | 
| MeSH | C006154 | 
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C14H16N2O3 | |
| Molar mass | 260.293 g·mol−1 | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Nadoxolol is an antiarrhythmic agent (i.e., a drug for the treatment of irregular heartbeat),[1] chemically related in structure to beta-adrenergic receptor blocker drugs such as propranolol.[2]
It does not appear to be marketed anywhere in the world.
References
- ↑ Warembourg, H; Ducloux, G (1976). "Clinical study of a new anti-arrhythmia agent: nadoxolol". Lille Med. 21 (4): 386–8. PMID 957857.
- ↑ Kapoor, M; Anand, N; Koul, S; Chimni, SS; Manhas, KS; Raina, C; Parshad, R; Taneja, SC; Qazi, GN (2003). "Kinetic resolution of 1-chloro-3-(1-naphthyloxy)-2-propanol, an intermediate in the synthesis of beta-adrenergic receptor blockers". Bioorganic Chemistry. 31 (3): 259–69. doi:10.1016/s0045-2068(03)00050-6. PMID 12818235.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
